Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer
NCT03122743 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61
Last updated 2022-03-10
Summary
This pilot research trial studies the collection of serum samples in studying emotional stress in patients with prostate cancer. Studying serum samples from patients with prostate cancer in the laboratory may help doctors determine if levels of epinephrine and cortisol, substances the body makes when stressed, rise or fall with how patients are feeling and/or if those levels are related to clinical information related to prostate cancer.
Conditions
- Hormone-Resistant Prostate Cancer
- Recurrent Prostate Carcinoma
- Stage I Prostate Cancer
- Stage II Prostate Cancer
- Stage IIA Prostate Cancer
- Stage IIB Prostate Cancer
Interventions
- PROCEDURE
-
Biospecimen Collection
Undergo collection of serum samples
- OTHER
-
Laboratory Biomarker Analysis
Correlative studies
- OTHER
-
Questionnaire Administration
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Bart Frizzell · Wake Forest University Health Sciences
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-22
- Primary Completion
- 2020-09-24
- Completion
- 2020-09-24
Countries
- United States
Study Locations
More Related Trials
-
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
NCT03575832 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
NCT00005827 ·Status: WITHDRAWN ·Phase: PHASE1
-
Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer
NCT00345813 ·Status: COMPLETED ·Phase: PHASE2
-
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005820 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
NCT00002924 ·Status: COMPLETED
-
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
NCT06070272 ·Status: NOT_YET_RECRUITING
-
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
NCT05586360 ·Status: RECRUITING ·Phase: PHASE2
-
North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)
NCT02564120 ·Status: COMPLETED
-
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
NCT03358563 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer
NCT02723526 ·Status: UNKNOWN
-
Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
NCT00293371 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
NCT04189770 ·Status: ACTIVE_NOT_RECRUITING
-
Collection of Blood in Studying Metabolites in Patients With Prostate Cancer
NCT03485794 ·Status: TERMINATED
-
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
NCT00455624 ·Status: COMPLETED
-
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT02008058 ·Status: COMPLETED
-
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
NCT03035500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Physical Function During ARSI Treatment
NCT05612880 ·Status: COMPLETED
-
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15
NCT00955435 ·Status: UNKNOWN
-
CCI-779 in Treating Patients With Prostate Cancer
NCT00012142 ·Status: COMPLETED ·Phase: PHASE2
-
To Live Better After Prostate Cancer Treatment:
NCT05100121 ·Status: RECRUITING ·Phase: NA
-
Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154
NCT00535834 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005960 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005810 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole
NCT01275651 ·Status: WITHDRAWN